Pharmacology of INS37217 [P1(uridine 5′)-P4 -(2′-deoxycytidine 5′)tetraphosphate, tetrasodium salt], a next-generation P2Y2receptor agonist for the treatment of cystic fibrosis

B. R. Yerxa, J. R. Sabater, C. W. Davis, M. J. Stutts, M. Lang-Furr, M. Picher, A. C. Jones, M. Cowlen, R. Dougherty, J. Boyer, W. M. Abraham, R. C. Boucher

Research output: Contribution to journalArticlepeer-review

136 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacology of INS37217 [P<sup>1</sup>(uridine 5′)-P<sup>4</sup> -(2′-deoxycytidine 5′)tetraphosphate, tetrasodium salt], a next-generation P2Y<sub>2</sub>receptor agonist for the treatment of cystic fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences